ID: MRFR/HC/7289-HCR | February 2023 | Region: Global | 117 Pages
The Lymphedema Diagnostics Market is projected to reach USD 30.29 Million by 2030 at 7.5% CAGR during the forecast period 2022-2030.
Market Synopsis
Lymphedema is a chronic condition that refers to swelling in any part of the body tissues, especially in the arms or legs. It develops due to damage to the lymphatic system. Sometimes it also develops after treatment of breast cancer.
Increasing the prevalence of cancer will support the growth of the market. According to the World Cancer Research Fund International, breast cancer was the most common cancer in women worldwide, contributing 25.4% of the total number of new cases diagnosed in 2018.
Lymphedema Diagnostics Market Influencer
High prevalence of lymphedema and cancer are likely to impact the growth of the lymphedema diagnostics market positively.
Market Drivers
Market Restraints
Lymphedema Diagnostics Market Segmentation
By Type
By Technology
By Disease Type
By End-User
Lymphedema Diagnostics Market By Region
Additionally, the presence of a large number of hospitals in the US is likely to support lymphedema diagnostics market growth. The US has over 7,200 active hospitals and a well-established healthcare sector
Lymphedema Diagnostics Market Key Players
Report Attribute/Metric | Details |
---|---|
Market Size | USD 30.29 Million |
CAGR | 7.5% |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Technology, Disease Type and By End-User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Siemens Healthineers, GE Healthcare, Stryker Corporation, Philips, Shimadzu Corporation, Canon, Inc., United Imaging Healthcare Co., Ltd., Hitachi, Ltd., Fluoptics, and Esaote SPA |
Key Market Opportunities | High prevalence of lymphedema and cancer are likely to impact the growth |
Key Market Drivers |
|
The lymphedema diagnostics market will generate revenue of USD 30.29 Million by 2030.
At a CAGR of 7.5%, the lymphedema diagnostics market would witness growth.
2022 to 2030 is the growth period of the lymphedema diagnostics market.
The market influencer for the lymphedema diagnostics market is the towering prevalence of lymphedema and cancer. These are liable to impact the development of the lymphedema diagnostics industry optimistically.
The Asia-Pacific is the fastest-growing regional market for the lymphedema diagnostics market.